FC

Frédéric André De Ceuninck

GN Galapagos Nv: 6 patents #45 of 177Top 30%
LS Les Laboratoires Servier: 3 patents #121 of 516Top 25%
Overall (All Time): #809,874 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11718588 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, David Amantini, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2023-08-08
10941117 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, David Amantini, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2021-03-09
10829478 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis Frédéric Gilbert LABÉGUÈRE, Rama Heng, Luke Jonathan Alvey, David Amantini, Franck Laurent Brebion +6 more 2020-11-10
10550100 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis Frédéric Gilbert LABÉGUÈRE, Rama Heng, Luke Jonathan Alvey, David Amantini, Franck Laurent Brebion +6 more 2020-02-04
10487060 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, David Amantini, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2019-11-26
9926281 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, David Amantini, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2018-03-27